Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase

被引:43
|
作者
Sonar, Vijay P. [1 ]
Corona, Angela [2 ]
Distinto, Simona [1 ]
Maccioni, Elias [1 ]
Meleddu, Rita [1 ]
Fois, Benedetta [1 ]
Floris, Costantino [3 ]
Malpure, Nilesh V. [4 ]
Alcaro, Stefano [5 ]
Tramontano, Enzo [2 ]
Cottiglia, Filippo [1 ]
机构
[1] Univ Cagliari, Drug Sci Sect, Dept Life & Environm Sci, Via Osped 72, I-09124 Cagliari, Italy
[2] Univ Cagliari, Dept Life & Environm Sci, Cittadella Monserrato SS554, I-09042 Cagliari, Italy
[3] Univ Cagliari, Dipartimento Sci Chim, I-09042 Cagliari, Italy
[4] SSGM Coll, Dept Bot, IN-423601 Kopargaon, MS, India
[5] Magna Graecia Univ Catanzaro, Dipartimento Sci Salute, Campus S Venuta,Viale Europa, I-88100 Catanzaro, Italy
关键词
Ocimum sanctum; HIV-1; RNase H; Reverse transcriptase; Triterpenes; Ferulic acid derivatives; RIBONUCLEASE H ACTIVITY; MOLECULAR-MECHANICS; BINDING-AFFINITY; ACTIVE-SITE; RNASE-H; DERIVATIVES; IDENTIFICATION; PARAMETERS; RECEPTORS; DISCOVERY;
D O I
10.1016/j.ejmech.2017.02.054
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Using an HIV-1 Reverse Transcriptase (RT)-associated RNase H inhibition assay as lead, bioguided fractionation of the dichloromethane extract of the Ocimum sanctum leaves led to the isolation of five triterpenes (1-5) along with three 3-methoxy-4-hydroxy phenyl derivatives (6-8). The structure of this isolates were determined by 1D and 2D NMR experiments as well as ESI-MS. Tetradecyl ferulate (8) showed an interesting RNase H IC50 value of 12.4 mu M and due to the synthetic accessibility of this secondary metabolite, a structure-activity relationship study was carried out. A series of esters and amides of ferulic and caffeic acids were synthesized and, among all, the most active was N-oleylcaffeamide displaying a strong inhibitory activity towards both RT-associated functions, ribonuclease H and DNA polymerase. Molecular modeling studies together with Yonetani-Theorell analysis, demonstrated that Noleylcaffeamide is able to bind both two allosteric site located one close to the NNRTI binding pocket and the other close to RNase H catalytic site. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:248 / 260
页数:13
相关论文
共 50 条
  • [21] MOLECULAR MODELING OF HIV-1 REVERSE-TRANSCRIPTASE INHIBITORS
    CRABBE, MJC
    FALKINGBRIDGE, SS
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (03) : 261 - 264
  • [22] Identification of novel bifunctional HIV-1 reverse transcriptase inhibitors
    Lai, Ming-Tain
    Tawa, Paul
    Auger, Anick
    Wang, Deping
    Su, Hua-Poo
    Yan, Youwei
    Hazuda, Daria J.
    Miller, Michael D.
    Asante-Appiah, Ernest
    Melnyk, Roman A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (01) : 109 - 117
  • [23] Non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Proudfoot, JR
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (08) : 971 - 982
  • [24] HIV-1 non-nucleoside reverse transcriptase inhibitors
    Högberg, M
    Morrison, I
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (08) : 1189 - 1199
  • [25] Design of Annulated Pyrazoles as Inhibitors of HIV-1 Reverse Transcriptase
    Sweeney, Zachary K.
    Harris, Seth F.
    Arora, Nidhi
    Javanbakht, Hassan
    Li, Yu
    Fretland, Jennifer
    Davidson, James P.
    Billedeau, J. Roland
    Gleason, Shelle K.
    Hirschfeld, Donald
    Kennedy-Smith, Joshua J.
    Mirzadegan, Taraneh
    Roetz, Ralf
    Smith, Mark
    Sperry, Sarah
    Suh, Judy M.
    Wu, Jeffrey
    Tsing, Stan
    Villasenor, Armando G.
    Paul, Amber
    So, Guoping
    Heilek, Gabrielle
    Hang, Julie Q.
    Zhou, Amy S.
    Jernelius, Jesper A.
    Zhang, Fang-Jie
    Klumpp, Klaus
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (23) : 7449 - 7458
  • [26] Disubstituted uracils as novel nonnucleoside inhibitors of HIV-1 reverse transcriptase inhibitors
    Valuev-Elliston, V.
    Babkov, D.
    Paramonova, M.
    Ivanov, A.
    Kochetkov, S.
    FEBS JOURNAL, 2013, 280 : 370 - 370
  • [27] Small molecule inhibitors targeting HIV-1 reverse transcriptase dimerization
    Grohmann, Dina
    Corradi, Valentina
    Elbasyouny, Mira
    Baude, Annika
    Horenkamp, Florian
    Laufer, Sandra D.
    Manetti, Fabrizio
    Botta, Maurizio
    Restle, Tobias
    CHEMBIOCHEM, 2008, 9 (06) : 916 - 922
  • [28] Structural modification of diarylpyrimidine derivatives as HIV-1 reverse transcriptase inhibitors
    Shuang-Xi Gu
    Yuan-Yuan Zhu
    Fen-Er Chen
    Erik De Clercq
    Jan Balzarini
    Christophe Pannecouque
    Medicinal Chemistry Research, 2015, 24 : 220 - 225
  • [29] DESIGN AND SYNTHESIS OF NOVEL INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE
    MARUENDA, H
    JOHNSON, F
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (12) : 2145 - 2151
  • [30] Structural modification of diarylpyrimidine derivatives as HIV-1 reverse transcriptase inhibitors
    Gu, Shuang-Xi
    Zhu, Yuan-Yuan
    Chen, Fen-Er
    De Clercq, Erik
    Balzarini, Jan
    Pannecouque, Christophe
    MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (01) : 220 - 225